Russian planes in Syria fly 316 sorties over five daysMilitary & Defense August 21, 15:55
Ka-226 helicopter to be first equipped with new crash-resistant fuel system by 2019Military & Defense August 21, 15:54
Putin appoints Anatoly Antonov Russia’s ambassador to USRussian Politics & Diplomacy August 21, 15:11
Russian senator blasts US visa suspension decision as 'dirty trick'Russian Politics & Diplomacy August 21, 15:09
Death toll in terrorist attacks in Catalonia grows to 15World August 21, 14:36
Expert says Russia halted global warming for one yearScience & Space August 21, 14:01
Moscow slams suspension of US visa procedures throughout RussiaRussian Politics & Diplomacy August 21, 13:58
Russia inks deal to launch two South Korean satellites on Soyuz rocketScience & Space August 21, 13:33
Poll reveals Russians take pride in country’s symbolsSociety & Culture August 21, 13:15
GENEVA, October 2. /TASS/. The World Health Organization (WHO) on Wednesday published new data, in line with which the death toll from the Ebola virus outbreak has reached 3,338 people out of a total of 7,178 officially registered cases.
The WHO report says the epidemic spread has slowed down for a second week. At the same time, the global health body warned that some cases could be underreported. The figures are cited as of the end of last week, September 28.
The Ebola virus disease (EVD), previously known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO website. The virus is passed on to people from wild animals and can be transmitted from humans to humans. The average EVD case death rate is some 50%
The first outbreaks of the EVD occurred in remote Central African villages, near tropical rainforests. However, major urban and rural areas have been involved in the most recent outbreak in western Africa.
Early supportive care, which includes rehydration and symptomatic treatment, improves the survival rate. No licensed treatment has yet been proven to be able to neutralize the virus but a number of blood, immunological and drug medications are under development. There are no licensed Ebola vaccines yet but two candidates are being evaluated.